跳至主要内容
临床试验/CTRI/2024/02/062381
CTRI/2024/02/062381
尚未招募
2 期

Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India

National Institutes of Health, National Cancer Institute1 个研究点 分布在 1 个国家目标入组 420 人开始时间: 2024年6月1日最近更新:

概览

阶段
2 期
状态
尚未招募
发起方
National Institutes of Health, National Cancer Institute
入组人数
420
试验地点
1
主要终点
HR-HPV persistence or 2 positive tests for the same HR-HPV type, separated by 12 to 18 months.

概览

简要总结

Using qualitative research methods, we plan to first refine a nurse-led, ASHA co-

delivered, nutrition-enhanced ASHA-Health HPV intervention, adapted for high-risk

group of women co-infected with HIV and HPV, and then conduct a parallel-group

cluster randomized control trial, assessing the efficacy of our ASHA-Health HPV

intervention, as compared with an enhanced Standard of Care (SOC+) (usual care +

3 sessions [wellness, basic nutrition and HPV/HIV health promotion]) among 420

high-risk co-infected women to prevent cervical cancer while remaining engaged in

the HIV treatment cascade, and managing nutritional health. Our Primary outcome is

HR-HPV persistence (2 positive tests for the same HR-HPV type separated by 6 or

12 months). Secondary outcomes will be improvement in: 1) HIV outcomes (HIV

viral load and CD4 count; 2) Nutritional indices (serum albumin, Vitamin A and

Vitamin D - for immune support; and Iron); 3) Mental health (depression, HIV

internalized stigma, and HPV/HIV stigma fears); and 4) Engagement in care

(HPV/HIV appointment keeping and ART adherence) at 6, 12, and 18 months.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
25.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • 1 WLH, 25 to 50 years of age per HIV-based guidelines 2 receiving ART for over two months to ensure medication stabilization, validated by an ART card given to all ART patients 3 screened as HPV positive with self sample vaginal collection 4 assessed to have oncogenic HPV and 5 assessed to be VIA negative for cervical lesions, performed by our trained Auxiliary Nurse Midwife (ANM).

排除标准

  • 1 pregnant or lactating women due to hormonal and dietary guideline differences 2 women below 25 years and 3 women determined to be VIA positive as they will be immediately referred to our Gynecology specialist.

结局指标

主要结局

HR-HPV persistence or 2 positive tests for the same HR-HPV type, separated by 12 to 18 months.

时间窗: 12, 18 months

次要结局

  • 1 HIV outcomes HIV(viral load and CD4 count 2 Nutritional indices serum albumin, Vitamin A and)

研究者

发起方
National Institutes of Health, National Cancer Institute
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Veena A Satyanarayana

National Institute of Mental Health and Neuro Sciences

研究点 (1)

Loading locations...

相似试验